Evidence map›Paper›PMID 15555827›Full record

ReviewInfectious disease clinics of North America2004

Empiric treatment of ambulatory community-acquired pneumonia: always include treatment for atypical agents.

Thomas J Marrie

Abstract readReview
In one paragraph

Review in Infectious disease clinics of North America, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. The atypical pneumonias: clinical diagnosis and importance.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2006
    Review
  3. Acute lung infections in normal and immunocompromised hosts.Radiologic clinics of North America · 2006
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Thomas J Marrie2J2.00 Walter C. Mackenzie Health Sciences Centre, 8440 112th Street, Edmonton, Alberta T6G 2R7, Canada. tom.marrie@ualberta.ca

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There are no data from proper studies to answer whether it is necessary to include antibiotics that are active against atypical pneumonia agents as part of the empiric therapy of CAP. Until such data are available, clinical judgment and severity of the pneumonic illness are the best guides to empiric antimicrobial therapy.

Indexed as

Anti-Bacterial AgentsChlamydia InfectionsChlamydophila pneumoniaeCommunity-Acquired InfectionsHumansLegionnaires' DiseasePneumonia, BacterialPneumonia, MycoplasmaQ FeverAnti-Bacterial Agents

Identifiers

PMID15555827
PMCPMC7118999

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.